CapitaLand Integrated Commercial Trust to Buy Paragon Mall for 3.85 Bln Singapore Dollars

SGX Filings
04/20

CapitaLand Integrated Commercial Trust (C38U) said on Apr, 20 2026 that its trustee has agreed to acquire all the units of Paragon Trust and the entire share capital of Orchard 290 from subsidiaries of Temasek Holdings for an estimated 3.848 billion Singapore dollars, giving the real-estate investment trust full ownership of the freehold Paragon property on Orchard Road.

The deal values the 714,900-sq-ft upscale retail, medical and office complex at 3.900 billion Singapore dollars, marginally above an independent valuation by Knight Frank and just below one by Cushman & Wakefield. After deducting 52.0 million Singapore dollars of net liabilities, the purchase price is set at about 3.848 billion Singapore dollars.

Including a 39.0 million Singapore dollar acquisition fee—payable in new units—and roughly 32.0 million Singapore dollars of related expenses, total outlay is projected at 3.919 billion Singapore dollars. CICT plans to fund the 3.880 billion Singapore dollars cash component through new debt, at least 600.0 million Singapore dollars in private-placement proceeds and funds from its planned sale of Asia Square Tower 2, or a bridging loan if that divestment closes later.

CICT said the purchase yield is about 3.9% and forecast a 2.1% increase in fiscal-2025 distribution per unit, while aggregate leverage is expected to edge up to 39.2%, remaining below the 50% regulatory ceiling.

Because the vendors are Temasek-linked entities, the transaction is deemed an interested person and interested party deal, requiring approval from unitholders at an extraordinary general meeting slated for the second or third quarter of 2026. Completion is targeted for the same period.

Post-acquisition and after the Asia Square Tower 2 divestment, CICT’s portfolio value is projected to rise to 28.7 billion Singapore dollars, with about 95% of assets located in Singapore and an increased share of integrated developments.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10